Enterprise data platform for healthcare systems
Clearsense is a healthcare data platform for hospitals and health systems.
AI Panel Score
6 AI reviews
Reviewed
AI Editor ApprovedApproved and published by our AI Editor-in-Chief after full panel analysis.Clearsense functions as a centralized data layer for healthcare organizations, pulling information from multiple disparate source systems into one platform called 1Clearsense. Health systems use this unified view to support day-to-day operational workflows, reduce reliance on multiple legacy vendors, and give staff access to consolidated patient and operational data without switching between systems.
The platform includes several named components. ReviveCS is a data archiving solution that allows organizations to retire legacy applications while keeping historical records accessible within current workflows, aimed at reducing technical debt and licensing costs from retained legacy systems. RevealCS focuses on research use cases, enabling EHR-based patient cohort matching to support clinical trial recruitment and research queries across unified patient data. Clearsense also offers a managed services option for application archival and decommissioning, positioned as an outsourced, end-to-end service for organizations looking to remove technical debt and prepare data for AI use without building this capability internally.
Clearsense is built for healthcare provider organizations, including hospitals and academic medical systems, rather than individual clinicians or small practices. The company states it has served over 500 hospitals and archived or decommissioned more than 750 applications for customers over four years. Pricing is not published and is arranged directly with Clearsense; the category includes vendors such as Harmony Healthcare IT and Legacy Data Access for data archiving, and health data platforms such as Health Catalyst for broader data enablement use cases.
Prepares archived and decommissioned application data for AI readiness as part of the outsourcing strategy.
Matches EHR-based patient cohorts to accelerate and streamline clinical research.
Helps healthcare organizations accelerate revenue recovery and maximize clinical trial revenue using platform data.
Consolidates data from multiple disparate sources into a single, holistic view for more efficient workflows.
Enables rapid, scalable cost savings through a cloud-native healthcare data platform.
Archives legacy application data and provides instant access to historical data within a user's current workflow.
Provides a scalable, cloud-native infrastructure for healthcare data enablement across enterprise systems.
Integrates data from disparate healthcare IT sources into a single, centralized platform for a unified view of data.
Assimilates data from multiple sources to create a holistic patient data view, as demonstrated for millions of patient records.
Provides end-to-end outsourced services to remove technical debt from legacy applications while decommissioning them.
Clearsense is an enterprise healthcare data platform sold to health systems and hospitals via a sales-led model; no public list pricing is published. Software Advice notes that for Clearsense, users are '"Confused about pricing? We've got you covered"' via a personalized quote rather than listed rates, and the product is also available via custom AWS Marketplace private offers. Pricing depends on factors like number of legacy applications being decommissioned/archived, data volume, and deployment scope, and requires contacting Clearsense directly for a quote.
Solid legacy-data cleanup story, but pricing opacity and thin funding data make this a board-level bet.
“500 hospitals served and $58M cited ROI at one system is real proof. No published pricing and no visible funding stage means you're negotiating blind.”
500 hospitals, 750 apps decommissioned, four years in market. That's not a startup pitch, that's an installed base. ReviveCS and RevealCS are named, specific, and solve a real problem: legacy EHR sprawl nobody wants to own.
Two questions I can't answer from what's here. Who funds them, and what's the real price floor once AWS Marketplace private-offer deals get negotiated? Health Catalyst and Harmony Healthcare IT compete here with more visible positioning.
The $100M "annual cost savings" claim is aggregate marketing, not your number. Speed to value depends entirely on how many legacy systems you're carrying — heavy legacy debt, this pays back fast. Light footprint, you're paying enterprise sales cycle costs for a problem you don't have yet.
Competes directly with Harmony Healthcare IT and Health Catalyst but lacks a public pricing page most peers now expect.
HITRUST certification and named health-system ROI claims make this defensible to a board, not sketchy.
Payback tied directly to legacy application volume being archived, so value timeline varies widely by customer.
Mostly cost-and-debt reduction via ReviveCS archiving, though RevealCS pushes toward research revenue, a genuine advance for systems running trials.
Four years in market and 500 hospitals served, but no public funding data or team size disclosed.
Health systems carrying heavy legacy application debt who need archiving and cohort-matching in one platform.
Skip if you're a smaller practice or your legacy footprint is already thin enough that Harmony Healthcare IT covers it cheaper.
Solid infrastructure play for legacy data debt, not a clinical decision-support tool I'd bring to my quality committee.
“Clearsense solves a real CIO-and-CFO problem: legacy application sprawl and technical debt. It's less clear this platform touches clinical workflow or bedside decision-making in ways my chief medical officer peers should care about day one.”
ReviveCS and the managed decommissioning service address a problem every health system CFO knows intimately — retained legacy licensing costs bleeding budget that should go to care delivery. The claimed $58 million ROI figure and 750+ applications archived across four years is a credible operational story, if unaudited. HITRUST certification is table stakes, not differentiation, against Harmony Healthcare IT and Legacy Data Access.
RevealCS is the piece that matters to me clinically: EHR-based cohort matching for trial recruitment. That's a research-ops win, not a bedside tool — it won't touch my clinical decision support stack or my quality dashboards. Over three years, this becomes infrastructure my CIO owns, not something my medical staff interacts with directly.
The tradeoff is real: strong data-debt remediation, little to show on clinical outcomes or physician workflow integration. Health Catalyst plays a broader analytics game; Clearsense is narrower and more archival-focused. Fine for the back office, not a clinical transformation lever.
Sits credibly against Harmony Healthcare IT for archiving; sized for 500+ hospital enterprise deployments, not smaller systems.
Built for CIO/IT operations, not clinician workflow — RevealCS touches research staff, not bedside care teams.
1Clearsense claims multi-EHR assimilation across millions of records, but no public API or docs to verify integration depth.
Reduces legacy vendor lock-in over time, but creates new dependency on Clearsense's own data layer with no published exit pricing.
Deep on archival/decommissioning craft (750+ apps over 4 years) but shallow on clinical analytics depth versus Health Catalyst.
Health systems carrying heavy legacy application debt who need archival and decommissioning before an AI or analytics push.
You're evaluating this for clinical decision support or bedside workflow improvement rather than back-office data infrastructure.
$58 million ROI claim. Zero dollars on the pricing page. That gap is the whole review.
“No published pricing, no free trial, quote-only via sales or AWS Marketplace private offer. Big claimed ROI numbers, small evidence trail on the contract terms that determine whether you see them.”
500 hospitals served. 750 applications archived. Four years of track record. Real scale, but none of it prices out without a call.
TCO math is unknowable from public materials. Pricing depends on legacy app count, data volume, deployment scope — meaning your quote could land anywhere. AWS Marketplace private offers exist, which at least routes spend through committed-use budgets. But no published tier, no floor, no ceiling.
$58M ROI on one regional system, $100M cited across customers overall. Impressive if verified, unverifiable from here. Compare to Harmony Healthcare IT or Legacy Data Access, both narrower archiving specialists with presumably simpler contracts, or Health Catalyst for the analytics layer. Clearsense bundles more — ReviveCS, RevealCS, managed decommissioning — which raises both the ceiling and the negotiation complexity. HITRUST certification is the one hard, checkable data point in the whole package.
AWS Marketplace private offer path eases procurement for enterprises already on AWS commit spend.
No published term length or renewal terms; enterprise health IT deals typically run multi-year with limited exit.
No pricing page, no tiers listed — quote-only, contact sales, per the pricing plan evidence.
$58M ROI and $100M savings figures are specific but come from vendor case studies, not audited third-party data.
Cost depends on app count and data volume with no published range; managed services add-on likely compounds spend.
Large health systems ready to retire legacy applications and willing to run a full procurement cycle.
You need comparable pricing across vendors before you'll even take the sales call.
Backend IT infrastructure play — not a clinician-facing tool, and that's the point.
“Clearsense lives in the data center, not the exam room. Whether it helps me on the floor depends entirely on whether my IT department wires RevealCS cohort matching into the research workflow correctly.”
This isn't something I open at the bedside — no clinician login, no app. It's plumbing: 1Clearsense pulls EHR data into one layer so legacy systems can get decommissioned. ReviveCS keeps old records queryable after a system's retired. Fine, if my hospital's IT team executes it well.
RevealCS is the piece that touches my world — cohort matching for clinical trial recruitment. If it actually surfaces eligible patients faster than manually screening the EHR, that's real time back for research coordinators. But there's no documentation here written for a clinical user, no sandbox, nothing I can test-drive. Everything routes through sales.
The $58 million ROI claim from one regional system is compelling on paper, but that's an administrator's metric, not a workflow one. Compare to Health Catalyst, which at least publishes analytics use cases clinicians can picture. Here, I'd need my CMIO to translate before I'd trust it day-to-day.
No clinician-facing interface described; daily experience depends entirely on IT's integration choices.
No docs, no API reference that I could find — the site reads as marketing copy, not practitioner guides.
Sales-led, no free trial, no published pricing — friction starts before a clinician ever sees the tool.
RevealCS cohort matching suggests depth for research teams, but no visible path from basic to advanced use.
ReviveCS promises historical data access within current workflow, but only RevealCS touches clinical research directly.
Health system IT and research informatics leaders retiring legacy applications and running EHR-based cohort recruitment.
You're a clinician or department lead looking for a tool you'll interact with directly.
A back-office data plumber for hospitals, not something anyone logs into for joy.
“Clearsense lives in the machine room, moving legacy data around so IT doesn't have to babysit old systems. That's genuinely useful, but there's no everyday user experience here to fall in love with.”
This isn't a tool you open every morning like Slack or Notion. It's infrastructure — ReviveCS archives legacy apps, RevealCS matches patient cohorts for research, and the whole thing sits behind a sales call. No pricing page, no free trial, nothing you can poke at yourself. Compare that to Health Catalyst or Harmony Healthcare IT, where at least the category norm is a discovery call and a demo, and Clearsense fits right in that mold, no better or worse.
The claimed numbers are real anchors though: 500+ hospitals served, 750+ applications decommissioned, one customer citing $58 million in ROI. That's not nothing. But there's no docs, no changelog, no visible product surface for me to judge day-to-day feel.
For IT and data teams, the win is fewer legacy licenses and less technical debt. For clinicians hoping for something delightful to use, this was never built for you, and it shows.
No docs, changelog, or pricing page publicly available — hard to judge sweated details from evidence given.
Named modules like ReviveCS and RevealCS suggest modular scope, but IT-admin complexity likely means a long ramp for staff.
Platform listed as web-only; no mobile mention anywhere I could find, which fits enterprise back-office tools but is still a gap.
Sales-led model with no free trial or self-serve path; onboarding is a procurement process, not a first-session experience.
HITRUST certification and claims of archiving data for 500+ hospitals suggest enterprise-grade stability, though unverifiable directly.
Hospital IT and data leaders trying to retire legacy systems and centralize records without building it in-house.
You're a smaller practice or individual clinician wanting a tool you can try today without a sales call.
$58 million ROI claim, zero pricing page. Fill in the blanks yourself.
“Clearsense looks like a real vendor with real hospital customers, not a vaporware pitch. But the exit story and the differentiation vs. Harmony Healthcare IT and Health Catalyst are both thin on public evidence.”
500 hospitals served, 750 applications decommissioned, four years of history. That's a real track record, not a launch-week claim. HITRUST certification is a legitimate signal for healthcare buyers who've seen too many 'secure' claims with no audit behind them.
But 'AI-Ready' is doing a lot of work in that features list — decommissioning legacy apps and prepping data for AI use are two different jobs wearing one badge. The $100 million 'annual cost savings for customers overall' figure has no methodology attached. Category norm is vague ROI math; this isn't unusual, but it isn't proof either.
Exit portability worries me more. Once ReviveCS has archived your legacy systems and 1Clearsense is your unified layer, you're structurally dependent — no API, no docs page, sales-led pricing via AWS Marketplace private offers. Health Catalyst at least has a broader analytics story. Clearsense's moat is narrower: archiving plus cohort matching. Fine niche, hard to leave.
Sits between archiving specialists like Harmony Healthcare IT and broader platforms like Health Catalyst without a sharp wedge.
No API or docs listed; once legacy apps are archived into 1Clearsense, unwinding that dependency is nontrivial.
No funding data or changelog cadence visible, but AWS Marketplace listing and HITRUST cert suggest enterprise-grade staying power.
Specific hospital counts ground the pitch, but 'AI-Ready' and unsourced $100M savings figures lean aspirational.
500 hospitals and 750 decommissioned apps over four years is a real, checkable pattern, not a pre-launch story.
Hospital systems drowning in legacy application licensing costs who want a managed decommissioning path.
You want transparent pricing or a self-serve evaluation before looping in procurement.
Common questions answered by our AI research team
ReviveCS is a data archiving solution that gives instant access to historical data in a single view within your current workflow, letting you retire legacy applications while keeping their data usable.
RevealCS accelerates clinical research by unifying EHR data for patient cohort matching, helping research teams find and match patients faster across integrated data sources.
Yes. The 1Clearsense Platform integrates data from disparate healthcare IT sources into a single, centralized view, unifying records like EHR data to improve workflows and analytics.
Yes. Clearsense's Managed Services offers end-to-end outsourced application archival and decommissioning, turning technical debt removal into cost savings, lower risk, and AI-ready data access.
Customers report significant savings, including one large regional healthcare system citing roughly $58 million in ROI, and Clearsense highlights $100 million in annual cost savings for customers overall.
Clearsense is a healthcare data enablement company based in Jacksonville, Florida, offering cloud-based solutions for data archiving, integration, and analytics.